… Read More
New PERSIST-AVR study results and SURE-AVR registry data analysis underscore utility of Perceval as a minimally invasive surgical approach for patients with aortic valve stenosis
LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced new data from the Perceval® Sutureless Implant Versus Standard-Aortic Valve Replacement (PERSIST-AVR) clinical study and the Sorin Universal Registry on Aortic Valve Replacement (SURE-AVR). Results from a PERSIST-AVR sub-analysis demonstrated better clinical outcomes for patients with aortic valve stenosis who received the Perceval sutureless surgical aortic valve via minimally invasive cardiac surgery (MICS) than patients who received a stented valve through the same access. Data from a SURE-AVR sub-analysis further supported positive findings for Perceval using MICS or full sternotomy. The results were presented during a series of presentations at the 34th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).
“The new PERSIST-AVR data presented at EACTS highlight that
… Read More
The MarketWatch News Department was not involved in the creation of this content.
Sep 23, 2020 (AmericaNewsHour) —
The Global Atrial Fibrillation Surgery Market was valued at USD 1,026.99 million in 2016 and is projected to reach USD 3,797.26 million by 2025, growing at a CAGR of 13.97% from 2017 to 2025.
The Atrial fibrillation surgery occurrence is becoming more frequent because of increasing geriatric population, also because of lifestyle changes in the young population. The efficiency of the surgeries is main factor considered to increase the growth of the market.
The Final Report will cover the impact analysis of COVID-19 on this industry:
Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10059361
1. Market Drivers
1.1 Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population
1.2 Technological advancements
1.3 Rising occurrence of diseases caused by lifestyle habits
… Read More
Learn about the benefits of being able to read The News-Star on the go.
The recent purchase of an ExcelsiusGPS signifies yet another first for Glenwood Regional Medical Center, a Steward Family Hospital that is rapidly becoming a local leader in the field of robotic guidance and navigation.
Glenwood is now home to a new ExcelsiusGPS, a platform technology designed to improve safety and accuracy within the operating room for patients undergoing spine surgery.
ExcelsiusGPS® assists orthopedic surgeons at Glenwood Regional Medical Center by improving visualization of patient anatomy; this helps optimize treatment and improve patient outcomes. The ExcelsiusGPS system also streamlines the surgical workflow and reduces radiation exposure for surgeons and staff.
This revolutionary robotic navigation platform is the world’s first technology to combine a rigid robotic arm and full navigation capabilities into one adaptable platform